SAGE – sage therapeutics, inc. (US:NASDAQ)
Stock Stats
News
5/2
04:45 pm
sage
Medium
ATTENTION Sage Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
5/2
04:45 pm
sage
Medium
Sage Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - SAGE
5/2
03:51 pm
sage
Low
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
5/2
10:00 am
sage
Low
An Investigation Has Commenced on Behalf of Sage Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SAGE Losses.
5/1
11:40 am
sage
Medium
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at JPMorgan Chase & Co. from $29.00 to $28.00. They now have an "overweight" rating on the stock.
4/25/2024
06:30 am
sage
-5.1%
MISS
2/14/2024
06:30 am
sage
6.5%
BEAT
11/7/2023
06:30 am
sage
-4.8%
MISS
5/1
11:22 am
Maintains
Overweight
Overweight
JP Morgan
Medium
-5.0%
4/26
12:05 pm
Maintains
Neutral
Neutral
Goldman Sachs
Low
-0.3%
4/26
12:05 pm
Maintains
Neutral
Neutral
Goldman Sachs
Low
-0.3%
4/26
12:05 pm
Maintains
Neutral
Neutral
Goldman Sachs
Low
-0.3%
4/26
11:55 am
Maintains
Sector Perform
Sector Perform
RBC Capital
Low
0.1%
4/25
07:16 am
sage
Medium
Form 10-Q Sage Therapeutics, Inc. For: Mar 31
4/25
06:46 am
sage
Medium
Form 8-K Sage Therapeutics, Inc. For: Apr 25
4/24
04:14 pm
sage
Low
Form ARS Sage Therapeutics, Inc. For: Dec 31
4/24
04:11 pm
sage
Low
Form DEFA14A Sage Therapeutics, Inc.
4/24
04:08 pm
sage
Low
Form DEF 14A Sage Therapeutics, Inc. For: Jun 10
Show more
Top News Gainers
2/29 SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 13.5%
3/13 SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 9.8%
4/3 Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 9.3%
12/10 Form 4 Sage Therapeutics, Inc. For: Dec 09 Filed by: IGUCHI KIMI 9.2%
4/19 SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating. 8.7%
12/5 Sage's oral depression therapy fails in late-stage trial; shares plunge [Reuters (UK)] 8.5%
12/5 SAGE Therapeutics Inc (NASDAQ: SAGE) had its price target lowered by analysts at Guggenheim from $200.00 to $110.00. They now have a "buy" rating on the stock. 7.1%
12/11 Sage Therapeutics: Insider Buying After Recent Debacle [Seeking Alpha] 5.8%
6/27 Sage Therapeutics to Host “Sage FutureCast” Webcast 5.4%
11/1 SAGE Therapeutics Inc (NASDAQ: SAGE) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 5.1%
Top News Decliners
12/5 Is SAGE Therapeutics Inc (SAGE) A Good Stock To Buy ? [Yahoo! Finance News] -59.7%
3/11 SAGE Therapeutics Inc (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Mizuho. They now have a $58.00 price target on the stock. -19.3%
2/27 SAGE Therapeutics Inc (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Mizuho. They now have a $69.00 price target on the stock. -17.4%
3/18 SAGE Therapeutics Inc (NASDAQ: SAGE) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. -12.5%
2/27 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics (SAGE) Investors With 100K+ Losses to Contact Its Attorneys: Firm Investigating Potential Securities Fraud -12.1%
8/30 Tocqueville Opportunity Is One Of The Best Mid-Cap Funds This Year [Forbes] -6.3%
12/16 Sage: In Need Of Authentic Smudging [Seeking Alpha] -6.0%
3/20 SAGE Therapeutics Inc (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $28.00 price target on the stock. -5.4%
3/5 SAGE Therapeutics Inc (NASDAQ: SAGE) is now covered by analysts at Citigroup Inc. They set a "buy" rating on the stock. -5.1%
3/4 Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) -4.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3